Xtant Medical Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Xtant Medical Holdings generated cash of -$9,515,000, which is less than the previous year. Cash used in financing activities reached the amount of $19,691,000 last year. Net change in cash is therefore -$14,584,000.
Cash Flow
| 2014 | -7.32M | -298.35K | 9.04M |
|---|---|---|---|
| 2015 | -9.09M | -73.57M | 84.57M |
| 2016 | -14.40M | -5.81M | 16.43M |
| 2017 | -543.18K | -1.60M | 2.42M |
| 2018 | 1.21M | -367K | 3.09M |
| 2019 | -413K | -544K | -603K |
| 2020 | -731K | -1.30M | -861K |
| 2021 | 439K | -1.89M | 17.49M |
| 2022 | -5.34M | -1.55M | 9.02M |
| 2023 | -9.51M | -24.78M | 19.69M |
XTNT Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.50M | 18.38M | 2.34M | 5.23M | 6.79M | 2.85M | 2.57M | 6.36M | 4.46M | 3.04M |
Operating activities | ||||||||||
Net income | 660K | -8.48M | -4.84M | -7.02M | -8.22M | -70.09M | -52.41M | -19.49M | -2.17M | -10.50M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.17M | 1.29M | 1.33M | 2.07M | 3.14M | 6.59M | 8.40M | 7.24M | 4.88M | 952.32K |
Stock-based compensation expense | 2.73M | 2.46M | 2.20M | 1.08M | 515K | 0 | 211.80K | 522.98K | 836.74K | 935.31K |
| Deferred income tax benefit | 2.73M | 2.46M | 2.20M | 1.08M | 515K | 0 | 211.80K | 522.98K | 836.74K | 935.31K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -8.73M | -3.94M | -319K | 2.89M | -647K | 2.53M | 4.74M | -2.68M | -5.51M | 283.62K |
Inventories | -1.88M | -1.15M | 2.62M | -5.79M | 692K | 40K | 2.12M | -4.07M | -545.71K | -17.39K |
Accounts payable | 2.98M | 875K | -332K | 101K | -4.27M | -3.01M | -1.63M | 319.09K | 644.14K | 715.70K |
Cash generated by operating activities | -9.51M | -5.34M | 439K | -731K | -413K | 1.21M | -543.18K | -14.40M | -9.09M | -7.32M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1.45M | -1.76M | -2.11M | -1.54M | -879K | -624K | -1.64M | -5.83M | -2.26M | -299.97K |
Acquisitions Net | -23.50M | 205K | 225K | 241K | 335K | 257K | 32.5K | 16.4K | -72.97M | 0 |
Cash generated by investing activities | -24.78M | -1.55M | -1.89M | -1.30M | -544K | -367K | -1.60M | -5.81M | -73.57M | -298.35K |
Financing activities | ||||||||||
Common Stock Issued | 14.01M | 9.31M | 18.42M | 620K | 0 | 6.81M | 178.45K | 3.08M | 2.63M | 5.86M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -201K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 5.94M | -291K | -36.95M | -471K | -455K | -359K | 2.25M | -144.6K | 82.46M | -825.35K |
Cash used in financing activities | 19.69M | 9.02M | 17.49M | -861K | -603K | 3.09M | 2.42M | 16.43M | 84.57M | 9.04M |
Net Change In Cash | -14.58M | 2.12M | 16.04M | -2.89M | -1.56M | 3.94M | 277.69K | -3.78M | 1.89M | 1.42M |
Cash at end of period | 5.92M | 20.50M | 18.38M | 2.34M | 5.23M | 6.79M | 2.85M | 2.57M | 6.36M | 4.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |